Wednesday, January 14, 2009

According to Jon Najarian's Tuesday Stock Blog, which biotech saw options trading spike on Eli Lilly deal rumors?


CNBC Bonus Bucks Trivia
CNBC Million Dollar Portfolio Challenge

Squawk on the Street

Question: According to Jon Najarian's Tuesday Stock Blog, which biotech saw options trading spike on Eli Lilly deal rumors?

Answer: DNDN
Subscribe to EF Hutton via Email

Follow EF Hutton on Twitter